ClinicalTrials.gg

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Program

Pyridoxine

Also written as “Doxylamine + Pyridoxine” and “Vitamin B12, Vitamin B6, Folic acid”.

Its studies are mostly in Nausea · Vitamin B 12 Deficiency, led by 2 companies.

Drug pagePyridoxine: every studyAll 53 studies of it, academic ones too, with its approvals, label and forms.
Furthest: phase 4, since Mar 11, 20243 company-led studies, 0 open or running

Who develops it

Each company that leads studies of it, as its sponsor page counts them.

CompanyStudies it leadsFurthest phaseFirst studyNext primary completion
Valenta Pharm JSC20 open or runningphase 1since Mar 11, 2024Aug 9, 2022none ahead
Medice Arzneimittel Pütter GmbH & Co KGits history only10 open or runningphase 4since May 1, 2025May 1, 2025none ahead

How these companies relate is not in the registry. A license or acquisition is shown only with a dated source, such as a company release or filing.

History and studies of Valenta Pharm JSC only; the figures above count every company.

History and what’s ahead

From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.

  1. Aug 9, 2022First study: no phase study in NauseaFirst studyNCT05498233 · 28 enrolled · Russian Federation
  2. Mar 11, 2024Phase 1 study in NauseaNCT06342778 · 28 enrolled · Russia

TargetBeta

Not stated by its company or a source we have read. Most early programs say nothing of it.

Studies

All 2 Valenta Pharm JSC leads, newest first. Each opens its study page.

StudyPhaseStatusPrimary completionSize
NCT06342778Nausea · Russia1CompletedMay 2, 202428
NCT05498233Nausea · Russian Federation–CompletedSep 19, 202228

How it is read

Names in the registry

  • “Doxylamine + Pyridoxine”, 2 entries
  • “Vitamin B12, Vitamin B6, Folic acid”, 1 entry

Conditions, from the studies’ own filings

First seen by our ledger Nov 13, 2026.

What this can’t show

  • Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
  • Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
  • Primary completion dates are the sponsors’ estimates and often move.
  • A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.